dm+d
417910004
Medicine Compliance Aid Stability
ExjadeNovartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
Exjade
Tablets dispersible 125mg, 250mg, 500mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Dispersible tablet so unsuitable.
29 March 2015